Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment
Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment: a Single-center, Prospective Cohort Study
RenJi Hospital
369 participants
Jun 1, 2022
OBSERVATIONAL
Conditions
Summary
Investigators will conduct this single-center, prospective cohort study to explore the prevalence and risk factors of renal function progression in post-liver transplantation patients with renal impairment after renal biospy and to understand the the pathology of kidney disease in post-liver transplantation patients with renal impairment.
Eligibility
Inclusion Criteria5
- age 18-75 years
- patients received liver transplantation
- new onset of proteinuria(defined as 24-hour proteinuria\>1g/24h, or Urinary albumin creatinine ratio(UACR)\>300mg/g on at least two occasions), and/or renal impairment: eGFR \<60 mL/min/1.73 m² at least two occasions, and/or serum creatinine increase ≥50% from baseline
- have received renal biopsy in the past 3 months
- Signed informed consent form(ICF)
Exclusion Criteria7
- patients received renal transplantation
- hepatic failure
- severe bleeding risk or platelet \<70\*109/L
- chronic kidney insufficiency with eGFR\<30ml/min·1.73m2,or kidney atrophy, or solitary kidney, or medullary sponge kidney, or polycystic kidney, or obstructive nephropathy
- uncontrolled mental disease or unable to cooperate during operation
- Pregnancy or lactation
- not suitable for this study judged by investigaters
Interventions
Standard percutaneous biopsy has been performed in all participants. Modification of treatment will be jointly decided by hepatologists and nephrologists based on the pathological results. All participants will be followed up for 96 weeks.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05326399